Concord Biotech Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹1342.80
Market cap
14,048 Cr
Stock P/E
50.4
P/B
6.97
Dividend yield
0.8%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales195 Cr457 Cr698 Cr1,017 Cr216 Cr526 Cr244 Cr430 Cr204 Cr247 Cr278 Cr326 Cr
Operating expenses (approx.)116 Cr251 Cr378 Cr552 Cr124 Cr288 Cr132 Cr230 Cr129 Cr145 Cr172 Cr192 Cr
EBITDA79 Cr206 Cr320 Cr465 Cr92 Cr238 Cr113 Cr200 Cr75 Cr102 Cr106 Cr134 Cr
OPM %40.4%45.1%45.9%45.8%42.4%45.3%46.1%46.5%36.8%41.2%38.0%41.1%
Other income7 Cr15 Cr23 Cr34 Cr10 Cr20 Cr15 Cr9 Cr14 Cr13 Cr10 Cr15 Cr
Interest0.75 Cr2 Cr2 Cr3 Cr0.24 Cr0.34 Cr0.10 Cr0.10 Cr0.06 Cr0.06 Cr0.08 Cr0.08 Cr
Depreciation13 Cr26 Cr40 Cr54 Cr13 Cr26 Cr13 Cr15 Cr18 Cr18 Cr19 Cr20 Cr
Profit before tax65 Cr178 Cr278 Cr409 Cr78 Cr211 Cr99 Cr185 Cr57 Cr83 Cr87 Cr114 Cr
Tax %25.4%25.4%25.4%25.5%25.5%25.8%25.4%23.3%25.6%27.1%25.9%22.4%
Net profit54 Cr136 Cr213 Cr308 Cr60 Cr155 Cr76 Cr140 Cr44 Cr63 Cr64 Cr88 Cr
EPS (₹)₹5.21₹12.95₹20.37₹29.45₹5.70₹14.85₹7.26₹13.42₹4.21₹6.03₹6.08₹8.46

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales1,017 Cr1,200 Cr1,055 CrSign in for TTM
Operating expenses (approx.)585 Cr649 Cr638 CrSign in for TTM
EBITDA432 Cr551 Cr416 CrSign in for TTM
OPM %42.4%45.9%39.5%Sign in for TTM
Other income34 Cr44 Cr52 CrSign in for TTM
Interest3 Cr0.53 Cr0.28 CrSign in for TTM
Depreciation54 Cr54 Cr74 CrSign in for TTM
Profit before tax409 Cr496 Cr342 CrSign in for TTM
Tax %25.5%24.8%25.0%Sign in for TTM
Net profit308 Cr372 Cr259 CrSign in for TTM
EPS (₹)₹29.45₹35.52₹24.78Sign in for TTM
Dividend payout %23.2%24.6%43.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr
Reserves1,516 Cr1,802 Cr2,007 Cr
Borrowings6 Cr0.38 Cr—
Other liabilities168 Cr221 Cr220 Cr
Total liabilities1,701 Cr2,034 Cr2,235 Cr
Fixed assets (net)572 Cr792 Cr786 Cr
CWIP211 Cr50 Cr78 Cr
Investments244 Cr335 Cr487 Cr
Other assets896 Cr1,176 Cr1,250 Cr
Total assets1,701 Cr2,034 Cr2,235 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity265 Cr245 Cr267 Cr
Cash from investing-155 Cr-160 Cr-143 Cr
Cash from financing-99 Cr-99 Cr-113 Cr
Net cash flow12 Cr-14 Cr11 Cr
Free cash flow (OCF − Capex)180 Cr133 Cr172 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %24.7%27.4%17.0%
ROE %20.2%20.5%12.9%
Debtor days125——
Inventory days411330467
Days payable187——
Cash conversion cycle350330467
Debt / equity0.00410.0002—
Current ratio6.306.177.39
Net debt / EBITDA-0.02-0.0010-0.03

Compare with peers

Loading peers…